Skip to main content
SpringerLink
Log in

Alcoholic Liver Disease

  • Chapter
Clinical Hepatology

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Akriviadis E, Botla R, Briggs W, et al (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroen-terology 119:1637–48

    Article  CAS  Google Scholar 

  2. Albano E (2006) Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 65:278–90

    Article  CAS  PubMed  Google Scholar 

  3. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209–18

    CAS  PubMed  Google Scholar 

  4. Bell H, Tallaksen C, Sjaheim T, et al (1993) Serum carbo-hydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases. Alcohol Clin Exp Res 17:246–52

    Article  CAS  PubMed  Google Scholar 

  5. Bellentani S, Saccoccio G, Costa G, et al (1997) Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 41:845–50

    Article  CAS  PubMed  Google Scholar 

  6. Bellentani S, Tiribelli C. (2001) The spectrum of liver disease in the general population: lesson from the Diagnosis study. J Hepatol 35:531–7

    Article  CAS  PubMed  Google Scholar 

  7. Bradford BU, Kono H, Isayama F, et al (2005) Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology 41:336–44

    Article  CAS  PubMed  Google Scholar 

  8. Burt AD, MacSwee R. (1999) Pathology of alcoholic liver disease. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodes J (eds) Oxford Textbook of clinical hepatology. Oxford University Press, Oxford, pp 1179–84

    Google Scholar 

  9. Caballeria J, Pares A, Bru C, et al (1998) Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver. J Hepatol 28:54–60

    Article  CAS  PubMed  Google Scholar 

  10. Cabre E, Rodriguez-Iglesias P, Caballeria J, et al (2000) Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multi-center randomized trial. Hepatology 32:36–42

    Article  CAS  PubMed  Google Scholar 

  11. Chedid A, Mendenhall CL, Gartside P, et al (1991) Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroentero l86:210–6

    Google Scholar 

  12. Cochrane J, Chen H, Conigrave KM, et al (2003) Alcohol use in China. Alcohol Alcohol 38:537–42

    PubMed  Google Scholar 

  13. Colmenero J, Bataller R, Sancho-Bru P, et al (2007) Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 132:687–97

    Article  CAS  PubMed  Google Scholar 

  14. Conn HO. (1982) Cirrhosis. In: Schiff ER, Schiff L (eds) Diseases of the liver. Lippincott, Philadelphia, pp 847–978

    Google Scholar 

  15. Corrao G, Arico S, Zambon A, et al (1997) Female sex and the risk of liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in Italy. Scand J Gastroenterol 32:1174–80

    Article  CAS  PubMed  Google Scholar 

  16. Crabb DW. (1997) First pass metabolism of ethanol: gastric or hepatic, mountain or molehill? Hepatology 25:1292–4

    Article  CAS  PubMed  Google Scholar 

  17. Dan Z, Popov Y, Patsenker E, et al (2005) Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential. FASEB J 19:845–7

    CAS  PubMed  Google Scholar 

  18. Day CP. (2006) From fat to inflammation. Gastroen-terology 130:207–10

    Article  CAS  Google Scholar 

  19. Denk H, Stumptner C, Zatloukal K. (2000) Mallory bodies revisited. J Hepatol 32:689–702

    Article  CAS  PubMed  Google Scholar 

  20. Dunn W, Jamil LH, Brown LS, et al (2005) MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 41:353–8

    Article  PubMed  Google Scholar 

  21. Dunn W, Angulo P, Sanderson S, et al (2006) Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology 131:1057–63

    Article  PubMed  Google Scholar 

  22. Falck-Ytter Y, Younossi ZM, Marchesini G, et al (2001) Clinical features and natural history of nonalcoholic steato-sis syndromes. Semin Liver Dis 21:17–26

    Article  CAS  PubMed  Google Scholar 

  23. Felver ME, Mezey E, McGuire M, et al (1990) Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14:255–9

    Article  CAS  PubMed  Google Scholar 

  24. Forrest EH, Evans CD, Stewart S, et al (2005) Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 54:1174–9

    Article  CAS  PubMed  Google Scholar 

  25. Frank A, Seitz HK, Bartsch H, et al (2004) Immunohistochemical detection of 1,N6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepato-carcinogene-sis. Carcinogenesis 25:1027–31

    Article  CAS  PubMed  Google Scholar 

  26. French SW, Barderyg-Gorce F (2005) Ubiquitin-protesasome pathway in the pathogenesis of liver disease. In: Dafour J, Clavier R (eds) Springer, Berlin, Heidelberg, New York, pp 377–90

    Chapter  Google Scholar 

  27. Frezza M, di Padova C, Pozzato G, et al (1990) High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 322:95–9

    Article  CAS  PubMed  Google Scholar 

  28. Garbutt JC, West SL, Carey TS, et al (1999) Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 281:1318–25

    Article  CAS  PubMed  Google Scholar 

  29. Gavaler J, Arria A. (1995) Increased susceptibility of women to alcoholic liver disease: artifactual or real?. In: Hall P (ed) Alcoholic liver disease. Edward Arnold, London/Boston/ Melbourne/Auckland, pp. 123–33

    Google Scholar 

  30. Gouillon Z, Lucas D, Li J, et al (2000) Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 224:302–8

    Article  CAS  PubMed  Google Scholar 

  31. Hall P (1995) Pathological spectrum of alcoholic liver disease. In: Hall P (ed) Alcoholic liver disease. Edward Arnold, London/Boston/Melbourne/Auckland, pp. 41–70

    Google Scholar 

  32. Halstedt C (1999) Role of nutrition in the treatment of alcoholic liver disease. In: Arroyo V, Bosch J, Bruguera M, Rodes J, Sanchez-Tapia J (eds) Masson, Barcelona, pp. 221–232

    Google Scholar 

  33. Higuchi S, Matsushita S, Imazeki H, et al (1994) Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet 343:741–2

    Article  CAS  PubMed  Google Scholar 

  34. Hurley T, Edenberg H, Li T (2002) Pharmacogenomics of Alcoholism. In: Licinio J, Wong M (eds) Pharmacogenomics — The search for individualized therapies. Wiley VCH, Weinheim

    Google Scholar 

  35. (2007). Neuland Verlagsgesellschaft mbH

    Google Scholar 

  36. Koch H, Meerkerk GJ, Zaat JO, et al (2004) Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: a systematic review. Alcohol Alcohol 39:75–85

    CAS  PubMed  Google Scholar 

  37. Lelbach WK. (1975) Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci 252:85–105

    Article  CAS  PubMed  Google Scholar 

  38. Leo MA, Kim C, Lowe N, et al (1992) Interaction of ethanol with beta-carotene: delayed blood clearance and enhanced hepatotoxicity. Hepatology 15:883–91

    Article  CAS  PubMed  Google Scholar 

  39. Lieber CS. (1994) Alcohol and the liver: 1994 update. Gastroenterology 106:1085–105

    CAS  PubMed  Google Scholar 

  40. Lieber CS. (1999) Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968–1998) — a review. Alcohol Clin Exp Res 23:991–1007

    CAS  PubMed  Google Scholar 

  41. Lieber CS. (2001) Alcoholic liver disease: natural course, mechanisms and therapeutic strategies. In: Boyer J, Blum H, Maier K, Sauerbruch T, Stalder G (eds) Liver cirrhosis and its development. Kluwer, Dordrecht

    Google Scholar 

  42. Lieber CS, Weiss DG, Groszmann R, et al (2003) II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res 27:1765–72

    CAS  Google Scholar 

  43. Lochs H, Plauth M. (1999) Liver cirrhosis: rationale and modalities for nutritional support — the European Society of Parenteral and Enteral Nutrition consensus and beyond. Curr Opin Clin Nutr Metab Care 2:345–9

    Article  CAS  PubMed  Google Scholar 

  44. Louvet A, Naveau S, Abdelnour M, et al (2007) The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 45:1348–54

    Article  CAS  PubMed  Google Scholar 

  45. Lumeng L, Crabb DW. (2001) Alcoholic liver disease. Curr Opin Gastroentero l17:211–20

    Article  Google Scholar 

  46. Maddrey WC, Boitnott JK, Bedine MS, et al (1978) Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75:193–9

    CAS  PubMed  Google Scholar 

  47. Maher J. (2002) Alcoholic liver disease. In: Feldman M, Friedman LS, Sleisenger MH, eds. Gastrointestinal and Liver Disease. Volume II. WB Saunders, Philadelphia, pp 1375–91

    Google Scholar 

  48. Mathurin P, Mendenhall CL, Carithers RL, Jr., et al (2002) Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 36:480–7

    Article  CAS  PubMed  Google Scholar 

  49. Mato JM, Camara J, Fernandez de Paz J, et al (1999) S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol 30:1081–9

    Article  CAS  PubMed  Google Scholar 

  50. McCullough AJ, O'Connor JF. (1998) Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 93:2022–36

    Article  CAS  PubMed  Google Scholar 

  51. Mendenhall C, Bongiovanni G, Goldberg S, et al (1985) VA Cooperative Study on Alcoholic Hepatitis. III: Changes in protein-calorie malnutrition associated with 30 days of hos-pitalization with and without enteral nutritional therapy. JPEN J Parenter Enteral Nutr 9:590–6

    Article  CAS  PubMed  Google Scholar 

  52. Mendenhall CL, Anderson S, Garcia-Pont P, et al (1984) Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 311:1464–70

    Article  CAS  PubMed  Google Scholar 

  53. Mendenhall CL, Moritz TE, Roselle GA, et al (1993) A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 17:564–76

    Article  CAS  PubMed  Google Scholar 

  54. Mezey E. (1998) Dietary fat and alcoholic liver disease. Hepatology 28:901–5

    Article  CAS  PubMed  Google Scholar 

  55. Moreau K, Mueller P, Driesch D, et al (1992) Trauma in cirrhosis: an indicator of the pattern of alcohol abuse in different societies. Alcoholism Clin Exp Res 16:141–3

    Article  Google Scholar 

  56. Morgan M. (1999) Alcoholic liver disease: natural history, diagnosis, clinical feature, evaluation, management, prognosis, and prevention. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodes J (eds) Oxford textbook of clinical hepa-tology. Oxford University Press, Oxford, pp 1186–238

    Google Scholar 

  57. Nair S, Mason A, Eason J, et al (2002) Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 36:150–5

    Article  PubMed  Google Scholar 

  58. Naveau S, Chollet-Martin S, Dharancy S, et al (2004) A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 39:1390–7

    Article  CAS  PubMed  Google Scholar 

  59. Niemela O. (2007) Acetaldehyde adducts in circulation. Novartis Found Symp 285:183–92; discussion 193–7

    Article  CAS  PubMed  Google Scholar 

  60. Nissenbaum M, Chedid A, Mendenhall C, et al (1990) Prognostic significance of cholestatic alcoholic hepatitis. VA Cooperative Study Group #119. Dig Dis Sci 35:891–6

    Article  CAS  PubMed  Google Scholar 

  61. Ohnishi K, Iida S, Iwama S, et al (1982) The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: relation to hepatitis B surface antigen carriage. Cancer 49:672–7

    Article  CAS  PubMed  Google Scholar 

  62. Oneta CM, Simanowski UA, Martinez M, et al (1998) First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying. Gut 43:612–9

    Article  CAS  PubMed  Google Scholar 

  63. Oneta CM, Lieber CS, Li J, et al (2002) Dynamics of cyto-chrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 36:47–52

    Article  CAS  PubMed  Google Scholar 

  64. Orrego H, Israel Y, Blake JE, et al (1983) Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity. Hepatology 3:896–905

    Article  CAS  PubMed  Google Scholar 

  65. Pequignot G. (1974) Les problemes nutritionelles de la soci-ete industrielle. La vie medicale en Canada francais 3:216–55

    Google Scholar 

  66. Purohit V, Brenner DA. (2006) Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology 43:872–8

    Article  CAS  PubMed  Google Scholar 

  67. Ramond MJ, Poynard T, Rueff B, et al (1992) A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 326:507–12

    Article  CAS  PubMed  Google Scholar 

  68. Raynard B, Balian A, Fallik D, et al (2002) Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35:635–8

    Article  PubMed  Google Scholar 

  69. Rehm J, Room R, Monteiro R, et al (2004) Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. In: Ezatti M, Murray C, Lopez AD, Rodgers A, Murray C (eds) Comparative quantification of health risks. World Health Organisation, Geneva

    Google Scholar 

  70. Salaspuro M. (1999) Epidemiological aspects of alcohol and alcoholic liver disease, ethanol metabolism, and pathogene-sis of alcoholic liver injury. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodes J (eds) Oxford textbook of clinical hepatology. Oxford University Press, Oxford, pp 791–810

    Google Scholar 

  71. Salaspuro MP (2003) Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Sci 40:183–208

    Article  CAS  PubMed  Google Scholar 

  72. Salmela KS, Roine RP, Hook-Nikanne J, et al (1994) Acetaldehyde and ethanol production by Helicobacter pylori. Scand J Gastroentero l29:309–12

    Article  Google Scholar 

  73. Saunders JB, Walters JR, Davies AP, et al (1981) A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 282:263–6

    Article  CAS  Google Scholar 

  74. Seitz HK, Meydani M, Ferschke I, et al (1989) Effect of aging on in vivo and in vitro ethanol metabolism and its tox-icity in F344 rats. Gastroenterology 97:446–56

    CAS  PubMed  Google Scholar 

  75. Seitz HK, Egerer G, Simanowski U. (1990) High blood alcohol levels in women. N Engl J Med 323:58–59

    Article  Google Scholar 

  76. Seitz HK, Oneta CM. (1998) Gastrointestinal alcohol dehy-drogenase. Nutr Rev 56:52–60

    Article  CAS  PubMed  Google Scholar 

  77. Seitz HK, Poschl G, Simanowski UA. (1998) Alcohol and cancer. Recent Dev Alcohol 14:67–95

    Article  CAS  PubMed  Google Scholar 

  78. Seitz HK, Suter P. (2002) Ethanol toxicity and nutritional status. In: Kotsonis F, Mackey M (eds) Nutritional toxicology, 2nd ed. Taylor & Francis, London/New York, pp 122–54

    Google Scholar 

  79. Seitz HK. (2006) Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase. Am J Clin Nutr 83:1252–3

    CAS  PubMed  Google Scholar 

  80. Seitz HK, Stickel F (2006) Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem 387:349–60

    Article  CAS  PubMed  Google Scholar 

  81. Seitz HK, Becker P (2007) Alcohol-induced hepatitis: Pathophysiology and treatment. In: Diehl A, Hayashy N, Manns M, Sauerbruch T (eds) Chronic hepatitis: metabolic, cholestatic, viral and autoimmun.: Kluwer, Dordrecht/ Boston/London, pp. 16–31

    Chapter  Google Scholar 

  82. Seitz HK, Stickel F (2007) Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7:599–612

    Article  CAS  PubMed  Google Scholar 

  83. Seth D, Gorrell MD, Cordoba S, et al (2006) Intrahepatic gene expression in human alcoholic hepatitis. J Hepatol 45:306–20

    Article  CAS  PubMed  Google Scholar 

  84. Simonis B, Reimann FM, Waldherr R, et al (2007) Sonographic course of alcoholic fatty liver by interobserver and digital evaluation of liver echogenicity. Zeitschr. Gastroenterol 45:689–96

    Article  CAS  Google Scholar 

  85. Slattery JT, Nelson SD, Thummel KE. (1996) The complex interaction between ethanol and acetaminophen. Clin Pharmacol Ther 60:241–6

    Article  CAS  PubMed  Google Scholar 

  86. Spahr L, Rubbia-Brandt L, Frossard JL, et al (2002) Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol 37:448–55

    Article  CAS  PubMed  Google Scholar 

  87. Stickel F, Urbaschek R, Schuppan D, et al (2001) Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease. Dig Dis Sci 46:2025–32

    Article  CAS  PubMed  Google Scholar 

  88. Stickel F, Schuppan D, Hahn EG, et al (2002) Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 51:132–9

    Article  CAS  PubMed  Google Scholar 

  89. Stickel F, Hoehn B, Schuppan D, et al (2003) Review article: Nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther 18:357–73

    Article  CAS  PubMed  Google Scholar 

  90. Stickel F, Osterreicher CH. (2006) The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol 41:209–24

    CAS  PubMed  Google Scholar 

  91. Teli MR, Day CP, Burt AD, et al (1995) Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346:987–90

    Article  CAS  PubMed  Google Scholar 

  92. Teschke R. (2003) Alkoholische Lebererkrankungen. In: Dancygier H, ed. Klinische Hepatologie. Springer Verlag,Berlin, pp 609–58

    Google Scholar 

  93. Thun MJ, Peto R, Lopez AD, et al (1997) Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 337:1705–14

    Article  CAS  Google Scholar 

  94. Thurman RG (1998) II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 275:G605–11

    CAS  PubMed  Google Scholar 

  95. Tilg H, Diehl AM (2000) Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343:1467–76

    Article  CAS  PubMed  Google Scholar 

  96. Tilg H, Jalan R, Kaser A, et al (2003) Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 38:419–25

    Article  CAS  PubMed  Google Scholar 

  97. Tilg H, Day CP. (2007) Management strategies in alcoholic liver disease. Nat Clin Pract Gastroenterol Hepatol 4:24–34

    Article  CAS  PubMed  Google Scholar 

  98. Urbaschek R, McCuskey RS, Rudi V, et al (2001) Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. Alcohol Clin Exp Res 25:261–8

    Article  CAS  PubMed  Google Scholar 

  99. Westin J, Lagging LM, Spak F, et al (2002) Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat 9:235–41

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This article is dedicated to my clinical teacher Professor Dr. Peter Czygan, Neuss, in gratitude for having guided me into Clinical Hepatology with broad knowledge and expertise based on scientific evidence, with curiosity and enthusiasm, but always with great empathy for the patient.

Author information

Authors and Affiliations

  1. Center of Alcohol Research, Liver Disease and Nutrition, University of Heidelberg, and Department of Medicine, Salem Medical Center, Zeppelinstr. 11–33, Heidelberg, 69121, Germany

    Helmut Karl Seitz (Professor of Medicine, Gastroenterology and Alcohol Research) & Sebastian Mueller

Authors
  1. Helmut Karl Seitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastian Mueller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Seitz, H.K., Mueller, S. (2010). Alcoholic Liver Disease. In: Clinical Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04519-6_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04519-6_34

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04509-7

  • Online ISBN: 978-3-642-04519-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation